Are you Dr. Srinivasan?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 51 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
28 Hill Rd
# A
Parsippany, NJ 07054Phone+1 973-335-9909Fax+1 973-335-9910
Summary
- Dr. Shankar Srinivasan, MD is a board certified psychiatrist in Parsippany, New Jersey. He is currently licensed to practice medicine in New Jersey, Louisiana, and Connecticut.
Education & Training
Yale-New Haven Medical CenterFellowship, Child and Adolescent Psychiatry, 2005 - 2007
Rutgers Health/New Jersey Medical SchoolResidency, Psychiatry, 2002 - 2005
University of the West Indies Faculty of MedicineClass of 2001
Certifications & Licensure
LA State Medical License 2015 - 2025
NJ State Medical License 2006 - 2025
CT State Medical License 2005 - 2008- American Board of Psychiatry and Neurology Psychiatry
Clinical Trials
- Efficacy Study of Inecalcitol With Decitabine in Acute Myeloid Leukemia Patients Unfit for Standard Chemotherapy Start of enrollment: 2016 Jun 01
Publications & Presentations
PubMed
- Impaired arbitration between reward-related decision-making strategies in Alcohol Users compared to Alcohol Non-Users: a computational modeling study.Srinivasan A Ramakrishnan, Riaz B Shaik, Tamizharasan Kanagamani, Gopi Neppala, Jeffrey Chen
NPP - Digital Psychiatry and Neuroscience. 2025-01-01 - 3 citationsImpact of darolutamide on local symptoms: pre-planned and post hoc analyses of the ARAMIS trial.Neal D Shore, Arnulf Stenzl, Christopher Pieczonka, Zachary Klaassen, William J Aronson
BJU International. 2023-04-01 - Darolutamide in Spanish patients with nonmetastatic castration-resistant prostate cancer: ARAMIS subgroup analysis.Joan Carles, Rafael A Medina-Lopez, Javier Puente, Álvaro Gómez-Ferrer, Javier Casas Nebra
Future Oncology. 2023-04-01
Press Mentions
Increasing Coverage, Decreasing Premiums Could Spearhead State Marketplace Platform ShiftAugust 18th, 2021
